Pennant Group Inc
$ 30.42
-0.39%
16 Apr - close price
- Market Cap 1,059,941,000 USD
- Current Price $ 30.42
- High / Low $ 30.95 / 29.96
- Stock P/E 36.36
- Book Value 9.54
- EPS 0.84
- Next Earning Report 2026-05-05
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.10 %
- 52 Week High 35.00
- 52 Week Low 21.73
About
The Pennant Group, Inc. provides health care services in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company is headquartered in Eagle, Idaho.
Analyst Target Price
$37.83
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-26 | 2025-11-10 | 2025-08-06 | 2025-05-05 | 2025-02-26 | 2024-11-06 | 2024-08-06 | 2024-05-06 | 2024-02-28 | 2023-11-07 | 2023-08-08 | 2023-05-04 |
| Reported EPS | 0.34 | 0.3 | 0.27 | 0.27 | 0.24 | 0.26 | 0.24 | 0.2 | 0.22 | 0.2 | 0.18 | 0.13 |
| Estimated EPS | 0.3157 | 0.295 | 0.27 | 0.2375 | 0.24 | 0.23 | 0.22 | 0.17 | 0.22 | 0.19 | 0.17 | 0.14 |
| Surprise | 0.0243 | 0.005 | 0 | 0.0325 | 0 | 0.03 | 0.02 | 0.03 | 0 | 0.01 | 0.01 | -0.01 |
| Surprise Percentage | 7.6972% | 1.6949% | 0% | 13.6842% | 0% | 13.0435% | 9.0909% | 17.6471% | 0% | 5.2632% | 5.8824% | -7.1429% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-05 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.25 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: PNTG
2026-04-16 06:40:17
The Pennant Group, Inc. (NASDAQ:PNTG) has received a consensus "Moderate Buy" rating from eight research firms, with an average 12-month price target of $37.00. The company recently surpassed earnings expectations, reporting $0.34 EPS against an estimated $0.31, and revenue of $289.32 million, exceeding forecasts of $275.20 million. Institutional investors hold approximately 85.9% of the company's stock, which is currently trading near $30.54.
2026-04-12 08:10:54
Intellectia AI recommends Pennant Group Inc (PNTG) as a good buy for beginner investors seeking long-term growth, despite a lack of immediate technical buy signals. The company demonstrated strong financial performance in Q4 2025 with significant revenue and net income growth. Analysts have raised price targets, indicating confidence in PNTG's future potential.
2026-04-12 01:09:26
The Pennant Group Inc. (NASDAQ: PNTG) is showing a mid-channel oscillation pattern with positive near-term sentiment potentially eroding a mid-term weak bias within a long-term strength context. An exceptional 40.4:1 risk-reward setup targets a 12.1% gain against a 0.3% risk. AI models have generated three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles and holding periods, emphasizing sophisticated risk management.
2026-04-06 07:40:51
This article provides working capital per share data for Pennant Group Inc (FWB:1ZU) listed on the Frankfurt Stock Exchange. It includes financial information and links to various features and services offered by TradingView, such as charting tools, market data, and community resources.
2026-04-05 08:39:58
JPMorgan Chase & Co. increased its stake in The Pennant Group, Inc. (NASDAQ:PNTG) by 288.4% in the third quarter, bringing its total holdings to 130,721 shares valued at approximately $3.30 million. The Pennant Group reported strong quarterly earnings, beating analyst estimates with an EPS of $0.34 and revenue of $289.3 million, and provided optimistic FY2026 EPS guidance. Analyst sentiment for PNTG is largely bullish, with a consensus "Moderate Buy" rating and a target price of $36.60.
2026-04-04 04:39:58
The Pennant Group, Inc. (PNTG) provides healthcare services, operating in Home Health and Hospice Services, and Senior Living Services segments across multiple US states. The stock closed at $29.66, down 2.27%, with an overnight price of $28.67. Analysts have an average target price of $37.83, with RBC Capital maintaining an "Outperform" rating and raising its price target to $41.
